𝔖 Bobbio Scriptorium
✦   LIBER   ✦

177Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5

✍ Scribed by Danthala, Madhav; Kallur, K. G.; Prashant, G. R.; Rajkumar, K.; Raghavendra Rao, M.

Book ID
121540914
Publisher
Springer
Year
2014
Tongue
English
Weight
369 KB
Volume
41
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical results of radionuclide therapy
Clinical results of radionuclide therapy of neuroendocrine tumours with90Y-DOTATATE and tandem90Y/177Lu-DOTATATE: which is a better therapy option?
✍ Jolanta Kunikowska; Leszek KrΓ³licki; Alicja Hubalewska-Dydejczyk; Renata MikoΕ‚aj πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 487 KB

## Purpose Peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues is a treatment option for patients with disseminated neuroendocrine tumours (NET). A combination treatment using the high-energy ^90^Y beta emitter for larger lesions and the lower energy ^177^Lu for